On or around 09/21/2018 (Ongoing date of last review)
Filing Date: September 20, 2018
According to the Complaint, Cocrystal Pharma, Inc. ("Cocrystal" or the "Company", f/k/a/ BioZone Pharmaceuticals, Inc.) is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.
The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants were engaged in a pump-and-dump scheme to artificially inflate Cocrystal’s stock price; (2) this illicit scheme would result in governmental scrutiny, including from the SEC; (3) Defendants failed to abide by SEC disclosure regulations; and (4) as a result, Defendants’ statements about Cocrystal’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Company & Securities Information
Defendant: Cocrystal Pharma, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: COCP
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Anthony Pepe, et al. v. Cocrystal Pharma, Inc., et al.
COURT: D. New Jersey
DOCKET #: 18-CV-14091
JUDGE: Hon. Kevin McNulty
DATE FILED: 09/20/2018
CLASS PERIOD START: 09/23/2013
CLASS PERIOD END: 09/07/2018
PLAINTIFF FIRMS NAMED IN COMPLAINT:
The Rosen Law Firm (South Orange) 609 W. South Orange Avenue Suite 2P , The Rosen Law Firm (South Orange), NJ 07079 (973) 313-1887 (973) 833-0399 ·
First Identified Complaint (FIC) Filings:
Class Action Complaint for Violations of the Federal Securities Laws
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available